Opportunity Information: Apply for RFA DA 23 040
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), released this funding opportunity to create a Coordinating Center (CC) for its HIV/AIDS and Substance Use Cohorts Program. The underlying program consists of multiple longitudinal cohort studies focused on HIV/AIDS in the context of both injection and non-injection substance use. These cohorts collectively generate extensive data and bio-specimens and support a wide range of research, including basic immunology and virology, studies of HIV prevention and treatment, and investigations into common co-morbidities and co-infections seen when HIV and substance use intersect. The main idea behind the announcement is that, while the individual cohorts are already productive, NIDA believes a dedicated coordinating structure is necessary to fully unlock the value of these resources, reduce duplication, increase consistency, and make collaboration easier and faster across studies and with outside investigators.
The Coordinating Center is intended to function as the connective hub across the NIDA-funded cohorts and NIDA program staff. A central expectation is that the CC will help optimize collaborations not only among the cohort investigators themselves, but also between the cohort program and other researchers who are not directly funded through the cohort mechanism. In practical terms, the CC is meant to improve the efficiency and reach of investigator-initiated research by making it clearer what data and specimens exist, how they can be requested and used, and how multi-cohort questions can be organized and answered. The opportunity also emphasizes infrastructure-like responsibilities rather than running an independent clinical trial, which aligns with the funding mechanism and the explicit "Clinical Trial Not Allowed" designation.
A key deliverable described in the opportunity is establishing a virtual repository. This concept generally implies an organized, searchable, and well-governed system that helps researchers discover and request access to available cohort data and bio-specimens, while respecting the ethical, legal, and consent-related constraints that apply to sensitive HIV and substance use information. The repository function is paired with an organizing role for leadership and governance: the CC is expected to facilitate the work of the cohorts Steering Committee (SC). The SC includes representatives from the NIDA-funded cohorts and NIDA staff, and the CC would support its operations, coordination, and communication so the cohorts can align on shared priorities, policies, and collaborative activities.
Administratively, this opportunity is offered as a cooperative agreement (U24), which usually means NIH/NIDA anticipates substantial programmatic involvement during the award period compared to a standard research grant. The Funding Opportunity Number is RFA-DA-23-040, and the listed CFDA number is 93.279. The activity area is categorized under Education and Health, reflecting that the award supports research-enabling coordination, data infrastructure, and collaboration rather than direct service delivery. The original closing date shown is 2022-08-10, and the posting (creation) date is 2022-04-26.
Eligibility is broad and includes many types of U.S.-based organizations and governments. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations (including those other than federally recognized governments); public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses. The announcement also explicitly highlights additional eligible categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.
At the same time, there are important limits related to non-U.S. participation. Non-domestic (non-U.S.) entities, including foreign organizations and foreign institutions, are not eligible to apply as the primary applicant. Non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components are allowed as defined in the NIH Grants Policy Statement, which typically means a U.S. applicant may include certain foreign elements in the project if justified and permissible under NIH policy, even though a foreign organization cannot serve as the applicant institution.
Overall, the opportunity is designed to strengthen and unify a network of HIV/AIDS and substance use cohorts by providing centralized coordination, governance support, and an access-oriented virtual repository. NIDA is essentially investing in shared infrastructure so that the cohorts' accumulated longitudinal data and bio-specimens can be used more strategically, rapidly, and collaboratively to answer emerging questions about HIV pathogenesis, prevention, and treatment in the real-world context of substance use, including the complex co-infections and co-morbidities that often accompany it.Apply for RFA DA 23 040
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2022-04-26.
- Applicants must submit their applications by 2022-08-10. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NIDA HIV/AIDS and Substance Use Cohorts Program Coordinating Center (RFA-DA-23-040)
What is this funding opportunity about?
This opportunity supports creation of a Coordinating Center (CC) for NIDA's HIV/AIDS and Substance Use Cohorts Program. The CC is intended to serve as the connective hub across multiple NIDA-funded longitudinal cohort studies and NIDA program staff, with a focus on coordination, collaboration, and shared infrastructure that helps researchers better use cohort data and bio-specimens.
Which agency is offering this award?
The opportunity is from the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH).
What is the Funding Opportunity Number?
The Funding Opportunity Number is RFA-DA-23-040.
What is the CFDA number listed for this opportunity?
The listed CFDA number is 93.279.
What funding mechanism is being used?
The award uses a cooperative agreement mechanism (U24). This generally indicates substantial programmatic involvement from NIH/NIDA during the project period compared to a standard grant.
Is this opportunity considered a clinical trial?
No. It is explicitly designated "Clinical Trial Not Allowed," reflecting that the CC is expected to provide coordination and infrastructure support rather than run an independent clinical trial.
What problem is NIDA trying to solve by funding a Coordinating Center?
NIDA notes that the individual cohorts are already productive, but a dedicated coordinating structure is needed to fully unlock the value of the data and bio-specimens, reduce duplication, increase consistency across studies, and make collaboration easier and faster among cohorts and with outside investigators.
What kinds of cohort studies are involved in the underlying program?
The program includes multiple longitudinal cohort studies focused on HIV/AIDS in the context of both injection and non-injection substance use.
What types of research do these cohorts support?
The cohorts collectively support a wide range of research, including basic immunology and virology, studies of HIV prevention and treatment, and investigations into co-morbidities and co-infections commonly seen when HIV and substance use intersect.
What is the Coordinating Center expected to do?
Based on the description provided, the CC is expected to act as a hub that improves coordination and communication across the NIDA-funded cohorts and NIDA program staff, and to optimize collaborations both among cohort investigators and with researchers who are not directly funded through the cohort mechanism.
How does the Coordinating Center help researchers who are not part of the cohorts?
A central expectation is that the CC will make it clearer what cohort data and bio-specimens exist, how they can be requested and used, and how multi-cohort research questions can be organized and answered, which is intended to improve the efficiency and reach of investigator-initiated research.
What is the "virtual repository" mentioned in the opportunity?
A key deliverable is establishing a virtual repository, described as an organized, searchable, and well-governed system to help researchers discover and request access to available cohort data and bio-specimens.
Does the virtual repository have to account for privacy and compliance considerations?
Yes. The repository is expected to respect ethical, legal, and consent-related constraints that apply to sensitive HIV and substance use information.
What is the Steering Committee (SC), and how does the Coordinating Center relate to it?
The cohorts Steering Committee includes representatives from the NIDA-funded cohorts and NIDA staff. The CC is expected to facilitate the work of the SC by supporting its operations, coordination, and communication so the cohorts can align on shared priorities, policies, and collaborative activities.
Is the Coordinating Center intended to replace the individual cohorts?
No. The CC is described as a coordinating structure that strengthens and unifies the network of cohorts by providing centralized coordination, governance support, and an access-oriented virtual repository, while the underlying cohorts continue their longitudinal work.
What is the activity area/category for this opportunity?
The activity area is categorized under Education and Health, reflecting coordination, data infrastructure, and collaboration support rather than direct service delivery.
When was this opportunity posted, and what closing date is listed?
The posting (creation) date is 2022-04-26, and the original closing date shown is 2022-08-10.
Who is eligible to apply?
Eligibility is broad and includes many U.S.-based organizations and governments, including state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations (including those other than federally recognized governments); public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses.
Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are explicitly highlighted among eligible applicant categories.
Are certain institution types specifically encouraged or highlighted as eligible?
Yes. The announcement explicitly highlights categories such as HBCUs, Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, faith-based or community-based organizations, regional organizations, and eligible federal agencies.
Can a foreign organization apply as the primary applicant?
No. Non-domestic (non-U.S.) entities, including foreign organizations and foreign institutions, are not eligible to apply as the primary applicant.
Can a non-domestic component of a U.S. organization apply?
No. Non-domestic components of U.S. organizations are also not eligible to apply.
Are any foreign components allowed at all?
Yes. Foreign components are allowed as defined in the NIH Grants Policy Statement. This typically means a U.S. applicant may include certain foreign elements in the project if justified and permissible under NIH policy, even though a foreign organization cannot be the applicant institution.
What is the overall goal of funding this Coordinating Center?
The goal is to strengthen and unify a network of HIV/AIDS and substance use cohorts by providing centralized coordination, governance support, and a virtual repository that enables more strategic, rapid, and collaborative use of longitudinal data and bio-specimens to address questions around HIV pathogenesis, prevention, and treatment in the real-world context of substance use, including co-infections and co-morbidities.
Browse more opportunities from the same category: Education, Health
Next opportunity: AD/ADRD, Adverse Childhood Experiences, and Social Determinants of Health Ancillary Studies of Existing Longitudinal Cohorts (R01 - Clinical Trial Not Allowed)
Previous opportunity: Limited Competition: Research Centers in Minority Institutions (RCMI) Clinical Research Network for Health Equity (UG3/UH3 - Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 23 040
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 23 040) also looked into and applied for these:
| Funding Opportunity |
|---|
| Pathogenic Mechanisms influencing Blood Brain Barrier function in HIV and Substance Use Disorders (R01 Clinical Trial Optional) Apply for RFA DA 23 012 Funding Number: RFA DA 23 012 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) Apply for PAR 22 182 Funding Number: PAR 22 182 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) Apply for PAR 22 183 Funding Number: PAR 22 183 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional) Apply for RFA CA 22 027 Funding Number: RFA CA 22 027 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Workshops on Computational and Analytical Research Methods (R25 - Clinical Trial Not Allowed) Apply for RFA DA 23 027 Funding Number: RFA DA 23 027 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required) Apply for RFA DA 23 008 Funding Number: RFA DA 23 008 Agency: National Institutes of Health Category: Education, Health Funding Amount: $400,000 |
| Treatments for Lewy Body Dementias and Frontotemporal Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required) Apply for RFA NS 22 056 Funding Number: RFA NS 22 056 Agency: National Institutes of Health Category: Education, Health Funding Amount: $400,000 |
| NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 22 187 Funding Number: PAR 22 187 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 22 188 Funding Number: PAR 22 188 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed) Apply for RFA AI 22 038 Funding Number: RFA AI 22 038 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,000,000 |
| Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - Clinical Trial Not Allowed) Apply for RFA DA 23 015 Funding Number: RFA DA 23 015 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) Apply for PAR 22 181 Funding Number: PAR 22 181 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) Apply for RFA DA 23 020 Funding Number: RFA DA 23 020 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) Apply for RFA DA 23 019 Funding Number: RFA DA 23 019 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) Apply for PAR 22 165 Funding Number: PAR 22 165 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) Apply for PAR 22 164 Funding Number: PAR 22 164 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional) Apply for PAR 22 198 Funding Number: PAR 22 198 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed) Apply for RFA CA 22 026 Funding Number: RFA CA 22 026 Agency: National Institutes of Health Category: Education, Health Funding Amount: $5,500,000 |
| Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional) Apply for PAR 22 199 Funding Number: PAR 22 199 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed) Apply for RFA DA 23 052 Funding Number: RFA DA 23 052 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 23 040", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
